Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E van der Ryst

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Research in Virology|April 30, 1998
Study of the immunogenicity of different recombinant Mengo viruses expressing HIV1 and SIV epitopesE Van der Ryst, T Nakasone, A Habel, et al.
AIDS (London, England)|April 19, 2000
Allelic frequencies of host genetic variants influencing susceptibility to HIV-1 infection and disease in South African populationsC Williamson, S A Loubser, B Brice, et al.
AIDS Research and Human Retroviruses|March 19, 1999
A predominantly HIV type 1 subtype C-restricted epidemic in South African urban populationsJ H Van Harmelen, E Van der Ryst, A S Loubser, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|November 6, 1998
Correlation among total lymphocyte count, absolute CD4+ count, and CD4+ percentage in a group of HIV-1-infected South African patientsE van der Ryst, M Kotze, G Joubert, et al.
Antiviral Chemistry & Chemotherapy|August 3, 2021
V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1-infected, treatment-experienced persons receiving optimized background regimensM E Lewis, P Simpson, J Mori, et al.
Antiviral Chemistry & Chemotherapy|June 23, 2021
Highly prevalent Russian HIV-1 V3-loop sequence variants are susceptible to maravirocM E Lewis, B Jubb, P Simpson, et al.
The Central African Journal of Medicine|April 2, 1999
Nutritional status of HIV-1 seropositive patients in the Free State Province of South Africa--laboratory parametersA M van Staden, H C Barnard, M Nel, et al.
Virology|May 26, 1997
Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virusM Girard, E van der Ryst, F Barré-Sinoussi, et al.
European Journal of Clinical Nutrition|April 14, 1999
Nutritional status of HIV-1 seropositive patients in the Free State Province of South Africa: anthropometric and dietary profileA Dannhauser, A M van Staden, E van der Ryst, et al.
AIDS (London, England)|June 19, 1998
Usefulness of HIV-1 V3 serotyping in studying the HIV-1 epidemic in South AfricaR Cheingsong-Popov, C Williamson, S Lister, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Research in Virology|April 30, 1998
Study of the immunogenicity of different recombinant Mengo viruses expressing HIV1 and SIV epitopesE Van der Ryst, T Nakasone, A Habel, et al.
AIDS (London, England)|April 19, 2000
Allelic frequencies of host genetic variants influencing susceptibility to HIV-1 infection and disease in South African populationsC Williamson, S A Loubser, B Brice, et al.
AIDS Research and Human Retroviruses|March 19, 1999
A predominantly HIV type 1 subtype C-restricted epidemic in South African urban populationsJ H Van Harmelen, E Van der Ryst, A S Loubser, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|November 6, 1998
Correlation among total lymphocyte count, absolute CD4+ count, and CD4+ percentage in a group of HIV-1-infected South African patientsE van der Ryst, M Kotze, G Joubert, et al.
Antiviral Chemistry & Chemotherapy|August 3, 2021
V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1-infected, treatment-experienced persons receiving optimized background regimensM E Lewis, P Simpson, J Mori, et al.
Antiviral Chemistry & Chemotherapy|June 23, 2021
Highly prevalent Russian HIV-1 V3-loop sequence variants are susceptible to maravirocM E Lewis, B Jubb, P Simpson, et al.
The Central African Journal of Medicine|April 2, 1999
Nutritional status of HIV-1 seropositive patients in the Free State Province of South Africa--laboratory parametersA M van Staden, H C Barnard, M Nel, et al.
Virology|May 26, 1997
Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virusM Girard, E van der Ryst, F Barré-Sinoussi, et al.
European Journal of Clinical Nutrition|April 14, 1999
Nutritional status of HIV-1 seropositive patients in the Free State Province of South Africa: anthropometric and dietary profileA Dannhauser, A M van Staden, E van der Ryst, et al.
AIDS (London, England)|June 19, 1998
Usefulness of HIV-1 V3 serotyping in studying the HIV-1 epidemic in South AfricaR Cheingsong-Popov, C Williamson, S Lister, et al.
Pageof 5